NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

Adynxx, Inc., a clinical-stage biotechnology company focused on pain and inflammation, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced an agreement to develop an oral, non-hormonal drug therapy with the potential to address the underlying mechanisms of endometriosis and significantly improve upon the standard of care. Under…

Synteract , an innovative CRO with biotech and pharmaceutical companies to market new drugs, has acquired KinderPharm, a pediatric ORC, the vocation is to advance the development of pediatric medicines in all phases of clinical research. Like Synteract, KinderPharm has extensive knowledge to help clients navigate the complex environments of…

Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the U.S. drugmaker said on Wednesday. Keytruda, among a class of medicines called PD-1 inhibitors, is Merck’s top selling drug and has already been approved…

Advanced Proteome Therapeutics Corporation, is pleased to announce very positive results from animal studies in collaboration with Heidelberg Pharma. Antibody–drug conjugates (ADCs) are an emerging class of therapeutic agents with the potential to revolutionize current treatment strategies and regimens to fight cancer. The combination of APC's proprietary site-selective protein modification…

AstraZeneca (AZN.L) has taken another step to refocus on priority drugs by selling U.S. rights to a treatment for infant lung infections to Swedish Orphan Biovitrum (SOBIV.ST) for an upfront fee of $1.5 billion. Around 130 AstraZeneca staff will transfer to Sobi as the Swedish company, widely known as Sobi,…

DNAtrix and Valo Therapeutics today announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology. DNAtrix's clinical stage oncolytic adenovirus platform and Valo's PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus) vaccination technology will be combined to generate a novel "armed oncolytic vaccine"…

Lannett Company, Inc today announced that it has entered into an agreement with Amneal Pharmaceuticals, Inc. (Amneal) with regard to Levothyroxine Sodium Tablets USP.  Under the agreement, Amneal will be Lannett's sole customer for Levothyroxine Sodium beginning December 1, 2018 through March 23, 2019, and will re-sell the products to…

Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB (a Life Sciences Research Institute in Belgium) to support therapeutic biologics discovery at its Discovery Sciences group. Bruno Dombrecht, Expert Scientist at VIB Discovery Sciences: “Geneious Biologics will…

Theravance Biopharma Inc and partner Mylan NV on Friday won U.S. regulatory approval for their treatment for a chronic lung condition that causes breathing-related problems. The treatment, Yupelri here, is a once-daily inhalable solution to be used by patients of chronic obstructive pulmonary disease (COPD), a lung disease characterized by…

Japanese drugmaker Takeda Pharmaceutical (4502.T) is set to win conditional EU antitrust approval for its $62-billion bid for London’s Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday. Last month, Takeda offered to divest Shire Plc’s pipeline compound SHP647 along…

loadmore..